COGT Stock | | | USD 7.86 0.10 1.29% |
Cogent Biosciences financial indicator trend analysis is way more than just evaluating Cogent Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cogent Biosciences is a good investment. Please check the relationship between Cogent Biosciences Total Current Liabilities and its Non Currrent Assets Other accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cogent Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in price.
For more information on how to buy Cogent Stock please use our
How to Invest in Cogent Biosciences guide.
Total Current Liabilities vs Non Currrent Assets Other
Total Current Liabilities vs Non Currrent Assets Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cogent Biosciences Total Current Liabilities account and
Non Currrent Assets Other. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Cogent Biosciences' Total Current Liabilities and Non Currrent Assets Other is 0.8. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Cogent Biosciences, assuming nothing else is changed. The correlation between historical values of Cogent Biosciences' Total Current Liabilities and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Cogent Biosciences are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Current Liabilities i.e., Cogent Biosciences' Total Current Liabilities and Non Currrent Assets Other go up and down completely randomly.
Correlation Coefficient | 0.8 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Current Liabilities
Total Current Liabilities is an item on Cogent Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cogent Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Cogent Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cogent Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cogent Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in price.
For more information on how to buy Cogent Stock please use our
How to Invest in Cogent Biosciences guide.At this time, Cogent Biosciences'
Selling General Administrative is comparatively stable compared to the past year.
Sales General And Administrative To Revenue is likely to gain to 2.09 in 2024, despite the fact that
Enterprise Value Multiple is likely to grow to
(2.00).
Cogent Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Cogent Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cogent Biosciences fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Cogent Stock Analysis
When running Cogent Biosciences' price analysis, check to
measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to
predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.